The Office of the Superintendent of Insurance will hold its annual public meeting to present and discuss the findings and recommendations contained in the 2025 Prescription Drug Price Transparency legislative report. The purpose of this meeting is to inform the public of the report’s contents and to provide an opportunity for public comments and questions. Members of the public are invited and encouraged to attend this virtual meeting. Participants will have the opportunity to submit questions and provide oral comments during the presentation. This meeting will be conducted virtually via Webex. To participate, click the link below or copy and paste it into your browser. No prior registration is required.

Meeting Details:

Date: June 26, 2026
Time: 2:00 pm
Format: Online via Webex
Webex Link: https://teams.microsoft.com/meet/284287490769003?p=RlMEO52OXI7yxaqxh2
Meeting ID: 284 287 490 769 003
Passcode: SM7Cz2AX

Thank you for your interest and participation. If you have any questions about this notice or the meeting itself, please feel free to reach out to:

Alejandro Amparan
Director of Pharmacy Benefits and Drug Compliance
Phone: 505-607-5996
Email: RxTransparency@osi.nm.gov

NOTICE OF PRESCRIPTION DRUG PRICE TRANSPARENCY ANNUAL MEETING